LETTER   Open Access    

Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?

    Show all affliationsShow less
More Information
  • 加载中
  • [1] March, W.A., Moore, V.M., Willson, K.J., et al. (2010). The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction 25, 544−551.

    View in Article CrossRef Google Scholar

    [2] Teede, H.J., Misso, M.L., Costello, M.F., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 89, 251−268.

    View in Article CrossRef Google Scholar

    [3] Tata, B., Mimouni, N.E.H., Barbotin, A.L., et al. (2018). Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med 24, 834−846.

    View in Article Google Scholar

    [4] Cimino, I., Casoni, F., Liu, X.H., et al. (2016). Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun 7, 10055.

    View in Article CrossRef Google Scholar

    [5] Xu, H., Feng, G., Shi, L., et al. (2023). PCOSt: A non-invasive and cost-effective screening tool for polycystic ovary syndrome. The Innovation (Camb) 4, 100407.

    View in Article Google Scholar

    [6] Zhang, X., Xu, H., Feng, G., et al. (2022). Sensitive HPLC-DMS/MS/MS method coupled with dispersive magnetic solid phase extraction followed by in situ derivatization for the simultaneous determination of multiplexing androgens and 17-hydroxyprogesterone in human serum and its application to patients with polycystic ovarian syndrome. Clin Chim Acta 538, 221−230.

    View in Article Google Scholar

    [7] Han, Y., Xu, H., Feng, G., et al. (2022). An online tool using basal or activated ovarian reserve markers to predict the number of oocytes retrieved following controlled ovarian stimulation: a prospective observational cohort study. Front Endocrinol (Lausanne) 13, 881983.

    View in Article CrossRef Google Scholar

    [8] Xu, H., Feng, G., Alpadi, K., et al. (2022). A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study. Front Endocrinol (Lausanne) 13, 821368.

    View in Article CrossRef Google Scholar

  • Cite this article:

    Xu H., Zhang X., Yang R., et al., (2023). Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?. The Innovation Medicine 1(1), 100010. https://doi.org/10.59717/j.xinn-med.2023.100010
    Xu H., Zhang X., Yang R., et al., (2023). Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?. The Innovation Medicine 1(1), 100010. https://doi.org/10.59717/j.xinn-med.2023.100010

Figures(1)     Tables(1)

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(2185) PDF downloads(462) Cited by(0)

Relative Articles

Article Contents

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint